Breaking News

Tweet TWEET

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation of White River Capital, Inc. (RVR), BioMimetic Therapeutics

  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation of White
  River Capital, Inc. (RVR), BioMimetic Therapeutics Inc. (BMTI) , Jeffries
         Group, Inc. (JEF) and Provectus Pharmaceuticals, Inc. (PVCT)

PR Newswire

NEW YORK, Nov. 21, 2012

NEW YORK, Nov. 21, 2012 /PRNewswire/ --

(Logo: http://photos.prnewswire.com/prnh/20120409/MM84375LOGO )

White River Capital, Inc.
Levi & Korsinsky is investigating the Board of Directors of White River
Capital, Inc. (NYSE MKT: RVR) for possible breaches of fiduciary duty and
other violations of state law in connection with the sale of the Company and
its subsidiary, Coastal Credit, LLC, to an affiliate of Parthenon Capital
Partners for $23 per share.

Click here to learn more about the investigation
http://zlk.9nl.com/white-river-capital-rvr. 

BioMimetic Therapeutics Inc.
Levi & Korsinsky is investigating the Board of Directors of BioMimetic
Therapeutics Inc. (NasdaqGS: BMTI) for possible breaches of fiduciary duty and
other violations of state law in connection with the sale of the Company to
Wright Medical Group Inc. (NasdaqGS: WMGI) under which shareholders BioMimetic
shareholders will receive $1.50 in cash and 0.2482 shares of Wright common
stock for each share of BioMimetic stock they own.

Click here to learn more about the investigation
http://zlk.9nl.com/biomimetic-bmti. 

Jeffries Group, Inc.
Levi & Korsinsky is investigating the Board of Directors of Jeffries Group,
Inc. (NYSE: JEF) for possible breaches of fiduciary duty and other violations
of state law in connection with the sale of the Company to its largest
shareholder, Leucadia National Corp. (NYSE: LUK) under which shareholders will
receive 0.81 Leucadia shares for each share of Jefferies stock they own,
representing an approximate value of $17.24 per share. At least one analyst
set a price target of $19.00 per Jefferies share.

Click here to learn more about the investigation
http://zlk.9nl.com/jefferies-group-jef, or call: 877-363-5972.

Provectus Pharmaceuticals, Inc.
Levi & Korsinsky, LLP is investigating Provectus Pharmaceuticals, Inc. (OTC
BB: PVCT), and its Board of Directors in connection with the compensation
provided to certain of its executive officers.

To get more information, click here:
http://zlk.9nl.com/provectus-pharmaceuticals-pvct, or call: 877-363-5972

Levi & Korsinsky is a national firm with offices in New York and Washington
D.C. The firm has extensive expertise in prosecuting securities litigation
involving financial fraud, representing investors throughout the nation in
securities and shareholder lawsuits. Attorney advertising. Prior results do
not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph Levi, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

SOURCE Levi & Korsinsky, LLP

Website: http://www.zlk.com
 
Press spacebar to pause and continue. Press esc to stop.